US Patent 8507661 Modified iRNA agents
Patent 8507661 was granted and assigned to Alnylam Pharmaceuticals on August, 2013 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
February 26, 2010
Date of Patent
August 13, 2013
Patent Application Number
12714298
Patent Citations Received
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 8507661 Modified iRNA agents
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
